The expressive levels of miR-200a-5p, TPO, CD56, Galectin-3, MC, CK19 and B-raf in benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma. This evidence concerns the gene KRT19 and thyroid gland papillary carcinoma.